CHEK2-associated breast cancer detected by contrast-enhanced mammography and breast MRI despite negative ultrasonography
Przegląd Lekarski – Jagiellonian Medical Review · 2025
DOI: 10.20452/jmr.2025.20019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Przegląd Lekarski – Jagiellonian Medical Review, 2025. Verfasst von Elżbieta Łuczyńska und 4 weiteren Autor:innen.
Abstract (Originalsprache)
A 40-year-old woman with a family history of breast cancer (mother affected) and confirmed CHEK2 mutation underwent routine surveillance.Previous annual ultrasonography (US) examinations, including two studies performed within the preceding year, revealed only benign cysts without suspicious features.Despite negative
Zitieren
APA
Łuczyńska, E., Kozieł, W., Malisz, P., Kulińska, K., & Rudnicki, W. (2025). CHEK2-associated breast cancer detected by contrast-enhanced mammography and breast MRI despite negative ultrasonography. Przegląd Lekarski – Jagiellonian Medical Review. https://doi.org/10.20452/jmr.2025.20019
Vancouver
Łuczyńska E, Kozieł W, Malisz P, Kulińska K, Rudnicki W. CHEK2-associated breast cancer detected by contrast-enhanced mammography and breast MRI despite negative ultrasonography. Przegląd Lekarski – Jagiellonian Medical Review. 2025. doi:10.20452/jmr.2025.20019
BibTeX
@article{uczyska2025,
author = {Łuczyńska, Elżbieta and Kozieł, Wojciech and Malisz, Piotr and Kulińska, Karolina and Rudnicki, Wojciech},
title = {CHEK2-associated breast cancer detected by contrast-enhanced mammography and breast MRI despite negative ultrasonography},
journal = {Przegląd Lekarski – Jagiellonian Medical Review},
year = {2025},
doi = {10.20452/jmr.2025.20019}
}
EUVIMED